KPKimberly R. Pechman

Kimberly R. Pechman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kimberly R. Pechman has a total of 93 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Arterial Spin Labeling Hemodynamic Indices Relate to Cognitive and Small Vessel Disease Trajectories Over 11 Years

    by W. Hudson Robb, Ava M. Santner, Panpan Zhang, Darcie S. Kim, T. Bryan Jackson, Niranjana Shashikumar, Kimberly R. Pechman, Yukti Vyas, Dandan Liu, L. Taylor Davis, et al.

    BACKGROUND: Hemodynamic insufficiency may contribute to the development of neuroimaging signs of cerebral small vessel disease (SVD). The arterial spin labeling (ASL) spatial coefficient of variation (ASL-sCoV) is a proxy marker of arterial transit time and may better capture SVD-related hemodynamic disturbances compared with ASL-derived cerebral blood flow. We investigated ASL-derived hemodynamic indices in relation to cognition and neuroimaging markers of SVD over an 11-year follow-up period. METHODS: Participants without dementia or stroke were enrolled in the Vanderbilt Memory and Aging Project, a longitudinal observational cohort study in Nashville, TN. Participants underwent serial multimodal 3T brain magnetic resonance imaging to quantify SVD burden and neuropsychological assessment from 2012 to 2024 (4.9±3.5 years mean follow-up). Pseudo-continuous ASL assessed cerebral blood flow and ASL-sCoV in total gray matter. Baseline ASL-sCoV and cerebral blood flow were individually related to the cross-sectional burden and longitudinal trajectory of each SVD neuroimaging marker (white matter hyperintensities, enlarged perivascular spaces, cerebral microbleeds, and lacunar infarcts) and cognitive performances using linear and linear mixed-effects regression models. Models were adjusted for demographics, cognitive status, Framingham Stroke Risk Profile (minus age), apolipoprotein E -ε4 status, intracranial volume (for SVD outcomes), and follow-up time (for longitudinal models). RESULTS: Among participants (n=667, 68±9 years, 18% mild cognitive impairment, 51% female), higher ASL-sCoV was cross-sectionally associated with SVD markers, including white matter hyperintensities and enlarged perivascular spaces ( p FDR -valuesp FDR =0.03) and accelerated decline in executive function, information processing, language, and visuospatial performances ( P 0.05) or longitudinally ( p FDR -values>0.06). CONCLUSIONS: ASL-sCoV may serve as an important hemodynamic measure for identifying perfusion deficits tied to SVD burden and progression. Readily derived from existing ASL data sets, ASL-sCoV could provide substantial insight into the longitudinal clinical consequences of SVD.

  • Open Access

    A comparative evaluation of multiple enlarged perivascular space segmentation tools

    by James D. LeFevre, W. Hudson Robb, Dandan Liu, T. Bryan Jackson, Kimberly R. Pechman, Niranjana Shashikumar, Yukti Vyas, Bennett A. Landman, L. Taylor Davis, Timothy J. Hohman, et al.


  • Open Access

    Association of MRI-Visible Perivascular Spaces With Longitudinal Cognitive Decline Over a Decade

    by Kyoko Kohno, Yunyi Sun, James D. LeFevre, W. Hudson Robb, T. Bryan Jackson, Dandan Liu, Yukti Vyas, Benjamin Sweely, Kimberly R. Pechman, Niranjana Shashikumar, et al.

    Cerebral small vessel disease (SVD) is the most common vascular contributor to dementia. SVD markers often coexist, contributing to difficulty assessing their independent contributions to cognitive domains. MRI-visible perivascular spaces (PVSs) are an emerging SVD marker visualized by MRI. We previously showed that basal ganglia PVSs cross-sectionally contribute to worse cognition, independent of other SVD markers. To further characterize the clinical relevance of PVS, we studied its role as a unique SVD marker of longitudinal cognitive decline. Participants without stroke or dementia were included in the Vanderbilt Memory and Aging Project, a longitudinal observational cohort study based in Nashville, TN. Participants completed 3T MRI at study entry to measure SVD burden (PVS volume fraction, white matter hyperintensities volume, lacune counts, and cerebral microbleeds counts). PVS volumes were segmented using a deep learning algorithm. Participants underwent comprehensive serial neuropsychological testing over an 11-year follow-up period (mean follow-up = 4.9 ± 3.1 years). Each SVD marker was related to longitudinal neuropsychological performances using a linear mixed-effects model adjusting for age, sex, race/ethnicity, education, baseline cognitive status, apolipoprotein E-ε4 presence, Framingham Stroke Risk Profile, and intracranial volume. Head-to-head comparisons simultaneously tested multiple statistically significant SVD markers. Among participants (n = 750, age 68 ± 9 years, 52% female), higher basal ganglia PVS burden at baseline was associated with worse longitudinal performances in Boston Naming Test (β = -29.63; 95% CI -56.66 to -2.60), Animal Naming (β = -33.09; 95% CI -65.66 to -0.51), Wechsler Adult Intelligence Scale IV Coding (β = -86.36; 95% CI -150.9 to -21.82), executive function composite (β = -9.51; 95% CI -14.33 to -4.68), Hooper Visual Organization Test (β = -26.06; 95% CI -50.53 to -1.59), and episodic memory composite (β = -7.05; 95% CI -11.9 to -2.21). In head-to-head comparisons, basal ganglia PVS remained independent associations with executive function composite (β = -7.47; 95% CI -12.84 to -2.10) and Hooper Visual Organization Test (β = -22.11; 95% CI -42.38 to -1.85). Basal ganglia PVS burden independently contributes to worse longitudinal executive function and visuospatial skills independent of other SVD markers, highlighting PVS as an emerging marker of domain-specific cognitive decline in aging. Although causation cannot be established, findings further support PVS as a vascular contributor to deep brain structure damage underlying cognitive decline over time.


  • Open Access

    Plasma von Willebrand Factor and ADAMTS13 Interact With APOE ‐ε4 in Predicting Longitudinal Brain Atrophy and Cognitive Decline Over a 9‐Year Follow‐Up

    by Hailey A. Adegboye, Yunyi Sun, Panpan Zhang, Dandan Liu, Omair A. Khan, Kahraman Tanriverdi, Antonina Risitano, Julia Libby, Khiry L. Patterson, Albert B. Arul, et al.

    Background: Von Willebrand factor (VWF) and ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif, 13) are linked to dementia risk, and limited evidence suggests apolipoprotein E ( APOE )‐ε4 alters VWF release. This study assessed whether baseline VWF and ADAMTS13 levels predict neurodegeneration and cognitive decline and evaluated effect modification by APOE‐ε4 carriership. Methods: Vanderbilt Memory and Aging Project cohort participants (n=332, 73±7 years, 59% male) completed serial blood draw, neuropsychological assessment, and brain magnetic resonance imaging over 6.4 years (range 1.4–9.7 years). Baseline plasma VWF and ADAMTS13 levels were quantified using mass spectrometry and Olink. Fully adjusted linear mixed‐effects models related protein×time and protein×APOE‐ε4×time interaction terms to longitudinal brain magnetic resonance imaging and neuropsychological outcomes. Results: Lower baseline ADAMTS13 predicted faster declines in language (β=0.11, P =0.01), information processing speed (β=0.27, P =0.001), executive function (β=0.01, P =0.03), episodic memory (β=0.01, P =0.03), and visuospatial ability (β=0.11, P =0.001) and faster increases in global (β=−0.29, P =0.01) and frontal (β=−0.17, P =0.01) white matter hyperintensity volumes. Associations between ADAMTS13 and faster rates of cognitive decline and white matter injury were driven by APOE ‐ε4 carriers. Models relating VWF to longitudinal outcomes were null. APOE ‐ε4 interacted with VWF on longitudinal gray matter volumetric outcomes, such that faster rates of global gray matter atrophy were observed with higher baseline VWF levels among APOE ‐ε4 noncarriers only (β=−1530.5, P APOE ‐ε4 allele.


  • Open Access

    Learning disentangled representations to harmonize connectome network measures

    by Nancy R. Newlin, Michael E. Kim, Praitayini Kanakaraj, Kimberly Pechman, Niranjana Shashikumar, Elizabeth Moore, Derek Archer, Timothy Hohman, Angela Jefferson, Daniel Moyer, et al.

    PurposeConnectome network metrics are commonly regarded as fundamental properties of the brain, and their alterations have been implicated in the development of Alzheimer’s disease, multiple sclerosis, and traumatic brain injury. However, these metrics are actually estimated properties through a multistage propagation from local voxel diffusion estimations, regional tractography, and region of interest mapping. These estimation processes are significantly influenced by choices specific to imaging protocols and software, producing site-wise effects.ApproachRecent advances in disentanglement techniques offer opportunities to learn representational spaces that separate factors that cause domain shifts from intrinsic biological factors. Although these techniques have been applied in unsupervised brain anomaly detection and image-level features, their application to the unique manifold structures of connectome adjacency matrices remains unexplored. Here, we explore the conditional variational autoencoder structure for generating site-invariant representations of the connectome, allowing the harmonization of brain network measures.ResultsFocusing on the context of aging, we conducted a study involving 823 patients across two sites. This approach effectively segregates site-specific influences from biological features, aligns network measures across different domains (Cohen’s D<0.2 and Mann–Whitney U-test<0.05), and maintains associations with age (2.71×10−02±2.86×10−03 error in years) and sex (0.92±0.02 accuracy).ConclusionsOur findings demonstrate that using latent representations significantly harmonizes network measures and provides robust metrics for multi-site brain network analysis.


  • DeepN4: Learning N4ITK Bias Field Correction for T1-weighted Images

    by Praitayini Kanakaraj, Tianyuan Yao, Leon Y. Cai, Ho Hin Lee, Nancy R. Newlin, Michael E. Kim, Chenyu Gao, Kimberly R. Pechman, Derek Archer, Timothy Hohman, et al.

    T1-weighted (T1w) MRI has low frequency intensity artifacts due to magnetic field inhomogeneities. Removal of these biases in T1w MRI images is a critical preprocessing step to ensure spatially consistent image interpretation. N4ITK bias field correction, the current state-of-the-art, is implemented in such a way that makes it difficult to port between different pipelines and workflows, thus making it hard to reimplement and reproduce results across local, cloud, and edge platforms. Moreover, N4ITK is opaque to optimization before and after its application, meaning that methodological development must work around the inhomogeneity correction step. Given the importance of bias fields correction in structural preprocessing and flexible implementation, we pursue a deep learning approximation / reinterpretation of the N4ITK bias fields correction to create a method which is portable, flexible, and fully differentiable. In this paper, we trained a deep learning network “DeepN4” on eight independent cohorts from 72 different scanners and age ranges with N4ITK-corrected T1w MRI and bias field for supervision in log space. We found that we can closely approximate N4ITK bias fields correction with naïve networks. We evaluate the peak signal to noise ratio (PSNR) in test dataset against the N4ITK corrected images. The median PSNR of corrected images between N4ITK and DeepN4 was 47.96 dB. In addition, we assess the DeepN4 model on eight additional external datasets and show the generalizability of the approach. This study establishes that incompatible N4ITK preprocessing steps can be closely approximated by naïve deep neural networks, facilitating more flexibility. All code and models are released at https://github.com/MASILab/DeepN4.


  • Open Access

    Empirical assessment of the assumptions of ComBat with diffusion tensor imaging

    by Michael E. Kim, Chenyu Gao, Leon Y. Cai, Qi Yang, Nancy R. Newlin, Karthik Ramadass, Angela Jefferson, Derek Archer, Niranjana Shashikumar, Kimberly R. Pechman, et al.

    Diffusion-weighted magnetic resonance imaging (dMRI) is a non-invasive imaging modality that provides insight into the white matter (WM) microstructure in the brain.1 In diffusion tensor imaging (DTI), the signal from a dMRI scan is modeled as tensors that describe the direction and degree of water diffusion at each voxel.2 One of the most common ways to study a DTI model is through scalar metrics. Two of the most common diffusion scalars are fractional anisotropy (FA), which describes the directedness of diffusion, and mean diffusivity (MD), which describes the average magnitude of diffusion. While DTI is limited in its ability to describe crossing axon fibers in the brain,2 it is still useful to study the changes in brain morphology due to disease or aging.3 – 5


  • Open Access

    The investigation of hippocampal free‐water as a biomarker for cognitive impairment and decline in older adults

    by Aditi Sathe, Niranjana Shashikumar, Elizabeth E. Moore, Kimberly R. Pechman, Bennett A. Landman, Katherine A. Gifford, Timothy J. Hohman, Angela L. Jefferson, Derek B Archer

    Background: While diffusion MRI derived free‐water (FW) metrics have shown promise in predicting cognitive impairment and decline in aging and Alzheimer’s disease (AD), it is unclear whether hippocampal FW metrics would be superior to traditional structural neuroimaging biomarkers (i.e., hippocampal volume, AD Schwarz Signature, AD McEvoy Signature). We examined the relationships between hippocampal FW metrics and traditional neuroimaging biomarkers with longitudinal memory and executive function.Method: Vanderbilt Memory & Aging Project participants [n = 298, age at baseline: 73 ± 7 years, 40% mild cognitive impairment (MCI)] underwent longitudinal neuropsychological assessment and brain MRI over a 7 year follow‐up (mean: 3 ± 2 years) period. Structural MRI was used to quantify hippocampal volume in addition to Schwarz and McEvoy signatures. Diffusion MRI in conjunction with the FW elimination technique was used to quantify hippocampal FW and FW‐corrected fractional anisotropy (FAFWcorr). Linear regression was used to determine the association of each biomarker with baseline memory and executive function. A subsequent competitive model analysis was conducted to determine how much additional variance was provided by each biomarker compared to the covariate only model, which included age, sex, race/ethnicity, apolipoprotein‐e4 status, cognitive status, and modified Framingham Stroke Risk Profile scores. Additionally, linear mixed‐effects regression was used to determine the association between baseline biomarker values with longitudinal memory and executive function scores. All analyses were corrected for multiple comparisons using the FDR procedure.Result: At baseline, all biomarkers (excluding hippocampal FAFWcorr) were significantly associated with cognitive performance (Table 1), with hippocampal FW exhibiting the most significant association for memory (pFDR = 3.92×10−6) and executive function (pFDR = 5.35×10−3). Competitive models revealed that hippocampal FW contributed the most unique variance beyond covariates for memory (ΔRadj 2 = 3.87%) and executive function (ΔRadj 2 = 1.59%). Longitudinal models (Table 2, Figure 1) largely mirrored cross‐sectional models by demonstrating that hippocampal FW was most significantly associated with longitudinal decline in memory (pFDR = 5.04×10−13) and executive function (pFDR = 6.15×10−5).Conclusion: This study shows that hippocampal FW is a sensitive biomarker for cognitive impairment and decline, and provides strong evidence for further exploration of this measure in aging and AD.

  • Open Access

    Sleep health and subjective cognitive decline in the Vanderbilt Memory and Aging Project

    by Kelsie M Full, Marissa A. Gogniat, Kimberly R. Pechman, Timothy J. Hohman, Angela L. Jefferson, Katherine A. Gifford

    Background: Identifying modifiable risk factors for Alzheimer’s disease (AD) and related dementias (ADRD) may reveal critical evidence for early prevention. It is commonly believed that poor sleep is an early symptom of neurodegeneration and ADRD. However, distinct neurobiological processes occur during sleep, and dysfunction of these processes may also contribute to AD pathogenesis. Less is known about poor sleep and associations with subjective cognitive decline (SCD), a clinical symptom occurring before overt cognitive impairment due to early pathological AD. This study investigated associations between objective and self‐reported measures of sleep health and SCD in a community‐based cohort of older adults.Method: Participants from the Vanderbilt Memory and Aging Project (n = 220; 74±7 years; 34% female) completed 7‐days of wrist actigraphy and self‐report measures for SCD [Everyday Cognition Scale (ECog)] and sleep quality [Pittsburgh Sleep Quality Index (PSQI)]. Actigraphy data was processed to estimate average nightly sleep duration, sleep efficiency, and wake after sleep onset. Linear regressions related objective and self‐report sleep health measures with total ECog score adjusting for age, sex, race/ethnicity, education, body mass index, depressive symptoms, Framingham cardiovascular risk score, and apolipoprotein E‐e4 carrier status.Result: In main effect models, longer sleep duration was associated with greater SCD (b = 0.05, p<0.01). In models adjusted for age, sex, race/ethnicity, and education, higher PSQI (indicative of poorer sleep quality) was associated with greater SCD (b = 1.06, p = 0.01); however, the association was no longer statistically significant in the fully adjusted model. No associations were observed between sleep efficiency or wake after sleep onset and SCD.Conclusion: In this community cohort of older adults, longer nightly sleep duration and self‐reported poor sleep quality were linked with higher SCD. Findings could suggest that abnormal sleep duration and poor sleep quality increase the earliest clinical symptoms of AD. Further investigations are needed to evaluate the potential pathways connecting sleep health to ADRD development.

  • Open Access

    The investigation of hippocampal free‐water as a biomarker for cognitive impairment and decline in older adults

    by Aditi Sathe, Niranjana Shashikumar, Elizabeth E. Moore, Kimberly R. Pechman, Bennett A. Landman, Katherine A. Gifford, Timothy J. Hohman, Angela L. Jefferson, Derek B Archer

    Background: While diffusion MRI derived free‐water (FW) metrics have shown promise in predicting cognitive impairment and decline in aging and Alzheimer’s disease (AD), it is unclear whether hippocampal FW metrics would be superior to traditional structural neuroimaging biomarkers (i.e., hippocampal volume, AD Schwarz Signature, AD McEvoy Signature). We examined the relationships between hippocampal FW metrics and traditional neuroimaging biomarkers with longitudinal memory and executive function.Method: Vanderbilt Memory & Aging Project participants [n = 298, age at baseline: 73 ± 7 years, 40% mild cognitive impairment (MCI)] underwent longitudinal neuropsychological assessment and brain MRI over a 7 year follow‐up (mean: 3 ± 2 years) period. Structural MRI was used to quantify hippocampal volume in addition to Schwarz and McEvoy signatures. Diffusion MRI in conjunction with the FW elimination technique was used to quantify hippocampal FW and FW‐corrected fractional anisotropy (FAFWcorr). Linear regression was used to determine the association of each biomarker with baseline memory and executive function. A subsequent competitive model analysis was conducted to determine how much additional variance was provided by each biomarker compared to the covariate only model, which included age, sex, race/ethnicity, apolipoprotein‐e4 status, cognitive status, and modified Framingham Stroke Risk Profile scores. Additionally, linear mixed‐effects regression was used to determine the association between baseline biomarker values with longitudinal memory and executive function scores. All analyses were corrected for multiple comparisons using the FDR procedure.Result: At baseline, all biomarkers (excluding hippocampal FAFWcorr) were significantly associated with cognitive performance (Table 1), with hippocampal FW exhibiting the most significant association for memory (pFDR = 3.92×10‐6) and executive function (pFDR = 5.35×10‐3). Competitive models revealed that hippocampal FW contributed the most unique variance beyond covariates for memory (ΔRadj2 = 3.87%) and executive function (ΔRadj2 = 1.59%). Longitudinal models (Table 2, Figure 1) largely mirrored cross‐sectional models by demonstrating that hippocampal FW was most significantly associated with longitudinal decline in memory (pFDR = 5.04×10‐13) and executive function (pFDR = 6.15×10‐5).Conclusion: This study shows that hippocampal FW is a sensitive biomarker for cognitive impairment and decline, and provides strong evidence for further exploration of this measure in aging and AD.